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Reduce Neonatal and Fetal Mortality in a Regional Referral Hospital in Accra, Ghana 
Abstract:  
Objective To evaluate the cost-effectiveness of a quality improvement intervention (QI) aimed at 
reducing neonatal and fetal mortality in Accra, Ghana. 
Design Quasi-experimental, time-sequence intervention, retrospective cost-effectiveness analysis 
Methods An integrated quality improvement model (developed jointly by Kybele and Regional 
Ridge Hospital (RRH) and piloted at RRH, a tertiary referral center in Accra, Ghana) was used 
from 2012 to 2016. The number of neonatal deaths and stillbirths prevented were estimated using 
the steady-state assumption of RRH’s neonatal mortality rates (NMR) and stillbirth rates, and also 
with Ghana’s neonatal mortality rate (NMR) as counterfactual. The costs were assessed in 2016 
Ghanaian cedi (GH ¢). The cost-effectiveness of the intervention was calculated as cost per 
disability-adjusted life years (DALY) averted. This was further subjected to probabilistic and one-
way sensitivity analyses to test the assumptions inherent in the calculations. 
Main outcome measures Cost-effectiveness acceptability curve (CEAC), which provides a 
measure of decision uncertainty surrounding the choice, and incremental cost-effectiveness ratio 
(ICER), which represents the cost per disability-adjusted life-year averted by the intervention 
compared to status quo. 
Results The intervention employed quality improvement approaches over a four-and-a-half-year 
period with a focus on the selection of clinical champions, training in leadership, and clinical care 
strengthening across various clinical areas resulting in numerous process improvements. From 
2012 to 2016, a total of 5734 neonates were admitted at Ridge Regional Hospital and were affected 
by the quality improvement intervention. The total budget for the program was GH ¢ 1,640,623. 
Based on conservative program estimates 182 (±99) neonatal deaths and 85 (±77) stillbirths were 
prevented amounting to 8418 (± 4046) DALYs averted. The probability that the QI intervention is 
cost-effective is 0.90 at a willingness to pay threshold (WTP) of GH ¢ 500. The results were found 
to be sensitive to the following parameters: DALYs averted, number of neonatal deaths, and 
number of stillbirths. 
Conclusion An integrated approach to system strengthening in referral hospitals has the potential 
to reduce neonatal and fetal mortality in low resource settings and is likely to be cost-effective. 
Sustained change can be achieved by building organizational capacity broadly and deeply across 
leadership and by developing clinical skills.   
Keywords cost-effectiveness, disability-adjusted life year, neonatal mortality, quality 




Globally, over the past 25 years, there has been significant progress in saving young 
children’s lives. The mortality rate of children aged 1-59 months declined by 62 percent worldwide 
from 1990 to 2016, but the rate of newborn deaths declined only by 49 percent. The majority of 
neonatal deaths occur at home in low resource settings against a backdrop of poverty, sub-optimum 
care seeking and weak health systems1. Prevention of neonatal death continues to be a high-priority 
for national governments and the global community. Although historic gains have been achieved 
by halving maternal and child mortality during the Millennium Development Goals (MDGs) era, 
there are immense regional variations. In 2015, over 3.9 million neonatal deaths occurred 
worldwide and approximately 40% neonatal deaths occurred in sub-Saharan Africa (SSA) 2. 
Within SSA, the neonatal mortality rates remain twelve times higher than in high-income 
countries3. If current trends persist, more than 60 countries accounting for 80% of the burden of 
neonatal deaths in 2016 will miss the Sustainable Development Goals (SDGs) target of reducing 
neonatal mortality to 12 deaths per 1000 live births by 20304.  
Ghana, a West African nation, has shown progress in the reduction of under-five mortality 
through 2008, but there has been a reversal in the reduction of under-five mortality from 2009 to 
20145. The predominant reason for this reversal is neonatal mortality, which increased from 30 to 
32 per 1000 live births during this period5. Neonatal deaths account for almost 40% of under-five 
deaths in Ghana and are a major cause of concern5. The three major causes of neonatal deaths 
worldwide are infections (36%, which includes sepsis, pneumonia, tetanus, and diarrhea), preterm 
and low birth weight (28%) and birth asphyxia (23%); with variations between countries 
depending on their level of health care6. In Ghana, the major causes of neonatal death are asphyxia 
(41%), sepsis (15%) and low birth weight and preterm birth (15%)7. However, other reasons 
account for 19% of neonatal deaths, and the precise cause of death remains unknown for these 
neonates. It is likely that the causes of neonatal deaths differ by region, differences in cultural 
practices, availability of teaching facilities, regional hospitals, and other social determinants of 
health7–10. 
Interventions and strategies to address the major causes of neonatal death differ from those 
needed to reduce the other under-five deaths4.Ensuring a continuum of quality care during 
pregnancy, labor, delivery and through neonatal period is key to reducing neonatal deaths as the 
predominant causes of neonatal deaths are entirely preventable11. Prevention of neonatal 
infections, for instance, is dependent on maternal health programs such as antenatal care, hygienic 
care and early and exclusive breastfeeding12. Skilled birth attendance and emergency obstetric care 
are the most cost-effective interventions for preventing deaths due to birth asphyxia 9,13. However, 
prevention strategies are not implemented effectively in low resource settings, resulting in 
critically ill neonates being referred to tertiary and regional hospitals for advanced care. These 
high-risk neonates often arrive late at these facilities7.Thus, tertiary and regional hospitals in low 
resource settings have high neonatal mortality rates (NMR) due to the high volume of critically ill 
neonates with more than half neonatal deaths being referred admissions14. Improvement efforts 
must target these high volume, low resource referral hospitals handling high-risk cases if any 
additional progress is to be made in reducing neonatal deaths. The heavy caseload and 
disproportionately large number of sick neonates make these referral hospitals complex 
environments that require innovative solutions15.  
Evidence-based interventions to improve neonatal care practices in Low and Middle-
Income Countries (LMICs) have sought to strengthen various components of the healthcare 
system. Early success in low resource setting is often achieved through an integrated, high-
coverage program of universal outreach and family-community care. However, the simultaneous 
expansion of clinical care of babies and mother is essential for further reduction of neonatal 
deaths9.Clinical best practice guidelines like WHO Essential Newborn Care Course16, Helping 
Babies Breathe17, Kangaroo Mother Care18, and  The S.T.A.B.L.E program19are some of the 
training packages that have been promoted in low resource settings. However, these interventions 
have had limited success15. 
Newer approaches such as quality improvement (QI) have been considered to improve 
neonatal and obstetric care in low resource settings. Franco and Marquez’s review of quality 
improvement (QI)  projects in 12 countries found significant gains in compliance with best 
practices and improved outcomes, often achieved within 6 to 12 months of initial 
implementation20. In Ghana, “Project Fives Alive!” used QI techniques to test and rapidly scale-
up a package of interventions to reduce preventable deaths in children under age five. Sixty-eight 
percent of the districts involved in this project have continued using QI practices to test and 
implement local solutions three years after project initiation21.  However, most of the QI programs 
have focused on a limited range of problems. In order to improve outcomes in these high caseload 
facilities, clinical, operational, and leadership challenges must be simultaneously addressed. 
Knowledge-based clinical skills training programs are not enough to overcome broad operational 
and leadership problems within resource constricted environments.  QI efforts must be inter-
disciplinary and delve deeper to determine data-driven root causes of neonatal mortality. We 
present an integrated model15 of systems strengthening to improve neonatal outcomes as part of 
the Making Every Baby Count Initiative22 (MEBCI). As discussed elsewhere, this approach proved 
highly cost-effective at reducing maternal and fetal mortality rates15,23,24.  
The majority of the cost-effectiveness analyses to reduce neonatal mortality in low resource 
settings assess preventive interventions, and a systematic review of such studies indicates that 
packages of care were more cost-effective than vertical interventions25. To the best of our 
knowledge, there are no published analyses that question whether QI interventions aimed at 
reducing neonatal mortality in low resource settings are cost-effective. Therefore, we present a 
cost-effectiveness analysis (CEA) of a QI intervention to reduce neonatal and fetal mortality in 
Ghana which is likely to be applicable to other low resource settings and also has the potential to 
bolster efforts of LMICs to reach SDGs by 203015. 
 
Methods 
This study summarizes the QI intervention and presents the cost-effectiveness of a four and 
a half year (May 2012- December 2016) collaboration between Kybele Inc.26, Program for 
Appropriate Technology in Health27 (PATH) and the Ghana Health Service (GHS) at the Ridge 
Regional Hospital (RRH) in Accra, Ghana. The principles of Kybele’s partnership models and the 
robust drivers of the successful partnership have been described elsewhere28.  Based on previous 
work of Kybele on the reduction of maternal mortality, the GHS invited Kybele in May 2012 to 
lead a QI program to reduce neonatal mortality, and in September 2013, Kybele and PATH 
received a grant from the Children’s Investment Fund29 to strengthen newborn care in six regional 
hospitals and RRH was one of the them22. 
The intervention of this study is an integral component of ‘Making Every Baby Count 
Initiative’ (MEBCI), a collaborative effort of Ghana Health Service (GHS), Kybele and PATH30 
to reduce the neonatal mortality rate (NMR, defined as a number of deaths during the first 28 
completed days of life per 1000 live births) and stillbirth rates (SBR, defined as intrapartum 
stillbirths per 1,000 live births) by 20%. MEBCI seeks to strengthen capacities and skills of 
healthcare personnel to improve quality of care around the time of birth for mothers and their 
babies. MEBCI utilizes a multi-faceted approach to:  (1) enhance health care provider clinical 
capacity through a detailed training curriculum, (2) ensure accessibility of basic resuscitation 
devices in the target health facilities, (3) enhance stakeholder ownership of newborn by liaising 
with relevant national and regional policymakers, facility managers, local communities and the 
general public, and 4) improve national leadership capacity to ensure that newborn care is featured 
prominently on the national health agenda and receives appropriate funding and sustainable 
uptake22. MEBCI was implemented in multiple regional hospitals but this study is limited to the 
intervention at Ridge Regional Hospital. 
Among the 10 regional referral hospitals, RRH has the highest volume obstetric unit and 
70% of deliveries are high-risk antenatal or peripartum referrals31.Furthermore, 15% of 
pregnancies at RRH require advanced emergency treatment for complications that are often 
difficult to predict or prevent32,33. In 2012, RRH experienced 940 in-born admissions to Neonatal 
Intensive Care Unit (NICU) that rose to 1309 admissions in 2015 and at the end of 2016, RRH 
managed 1184 neonates. From the baseline year to the end of intervention in 2016, the crude NICU 
mortality reduced by 37% and the mortality of in-born neonates reduced by 43% neonates 
(institutional database, not published). The NICU was renovated in 2013 but resources were not 
available to significantly increase manpower during the intervention period. Instead, volunteers 
from high-volume neonatology, pediatric and anesthesiology departments in the United States 
made triannual visits to Ghana to coach and mentor providers and administrators at RRH to 
optimize the protocols and processes through systematic quality improvement.  
A customized model was developed jointly by Kybele-RRH team after identifying 
deficiencies in care delivery which has been published previously15.  We summarize the essential 
features of the intervention and present limited implementation details of the intervention. Focus 
groups and structured observations by visiting experts laid the foundation for leadership 
development and QI training. Key personnel was selected to act as clinical champions. 
Performance gaps in each clinical care area were identified through the analysis of processes and 
baseline outcome data. Training modules were delivered to address gaps in leadership, QI, 
newborn resuscitation, CPAP training, and obstetric triage focusing on solutions that addressed 
the drivers. Fifty-seven training sessions on 13 different activities were conducted over the 
intervention period (Table 1). RRH staff was coached through QI projects to test, adapt, and 
implement solutions. The learning modules on triage, newborn resuscitation, QI, leadership were 
completed. However, training modules like labor and delivery, NICU general care and theatre, and 
recovery training module were not completed due to funding withdrawal and diversion of 
resources to other regional hospitals (Figure 1). An electronic database and local data sources were 
used to collect accurate information on neonatal outcomes and their drivers. The Institutional 
Review Board approval was granted by Wake Forest University and the GHS for the conduct of 
this work. 
 
Table 1: Training modules conducted at Ridge Regional Hospital 
CPAP- Continuous Positive Air Pressure; NICU – Neonatal Intensive Care Unit. Training modules 
conducted at Ridge Regional Hospital from 2012 to 2016 along with the number of sessions and 
participants for each module  
 
Training module  Sessions conducted Number of Participants 
Labor and Delivery  3 61 
Triage Training 8 63 
Neonatal Resuscitation 9 120 
CPAP Training 8 42 
Quality Improvement 4 37 
NICU Hand Washing 1 19 
Individual Coaching Sessions 9 30 
Leadership Charter 1 25 
Emotional Intelligence/Leadership Styles 3 22 
Accountability 3 22 
Leadership Ambassador Training 1 6 
Clinical Champion Training 1 9 
Compassionate Care 6 140 

































































































































        
Figure 1: Activities completed at Ridge Regional Hospital. NICU- Neonatal Intensive Care 
Unit; QI – Quality Improvement. The green boxes represent fully completed training modules; 
yellow box represents partially completed training modules; red boxes represent incomplete  
training modules;  
The integrated approach to system strengthening in RRH is unique in that it did not focus 
primarily on providing materials commonly associated with healthcare costs, such as medications 
and supplies. The goal of the approach was to identify gaps and create processes that enabled the 
staff to use their resources more efficiently. For instance, redesigning the workflow to create a 
triage process did not require hiring new staff, but rather shifting roles to make things more 
efficient for staff and safer for women and neonates31. Instituting morning meetings where doctors, 
house officers, and midwives communicate daily are cost-neutral but appear to have been highly 
effective in improving team communication23,34. 
Essential newborn care and other clinical skills were imparted not as a routine clinical 
package but on the basis of individualized skills and training gaps. After each training module, the 
outcome data were collected for each improvement project and also at the institutional level. For 
instance, the neonatal resuscitation module resulted in improved stimulation of a baby, initiating 
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Recovery 
        
QI 
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positive pressure ventilation (PPV) within 1 min, improved communication with team member 
and performing corrective steps to ventilation. However, real-time observations indicated that 
assessing a baby’s condition after 30 seconds and giving effective PPV as noted by chest rise 
wasn't satisfactory. Overall, RRH staff conducted resuscitation better but were still missing the 
“golden minute35” (Table 2).  






Skill Observed  
Post-Training 
(%) p-value 
Stimulates baby appropriately (i.e. no 
slapping) 47/49 (96)  39/39 (100) 0.21 
Assess baby's condition after 30s 
(heart rate, apnea) 25/38 (66) 36/39 (92) <0.01 
Initiates positive pressure ventilation 
within 1 min if the baby is apneic 7/11 (64) 8/12 (67) 0.89 
Gives effective PPV noted by chest rise 2/8 (25) 9/10 (90) <0.01 
Reassesses heart rate and breathing 
after 30 secs 2/9 (22) 6/10 (60) 0.10 
Communicates with team member if 
condition poor 1/4 (25) 5/7 (71) 0.16 
Performs corrective steps to ventilation 
if PPV is not effective and HR>60  1/6 (17) 1/2 (50) 0.38 
PPV – Positive Pressure Ventilation; HR – Heart rate;  
Another essential emergency skill that was imparted to NICU and RRH staff was bag-
valve-mask(BVM) ventilation. Studies show that approximately 10% of newborn normally require 
assistance to begin breathing at birth and about 1% require extensive resuscitative measures36. At 
RRH,  nine sessions were conducted on neonatal resuscitation and 120 participants were trained. 
The pre-training results indicated that 40% of the participants didn’t have any resuscitation skills 
which subsequently declined to 1% in 2016.  Meanwhile, the number of participants capable of 
performing BVM ventilation increased from 11% in 2014 to 51% in 2016. While there was an 
increase in the use of BVM ventilation in severely asphyxiated babies at 1 minute (Figure 2) there 
was an even greater increase in BVM ventilation at 5 minutes (Figure 3).  
Figure 2: Newborn resuscitation: Apgar score (0-3) at 1 min. This bar diagram shows the 
resuscitation skills of RRH staff during pre-training in 2014, mid-training in 2015 and post-
training in 2016. The blue bars represent participants who didn’t have resuscitation skills; the red 
bar represents participants using oxygen and suction; the green bars represent participants 






































Figure 3: Newborn resuscitation: Apgar score (0-3) at 5 min. This bar diagram shows the 
resuscitation skills of RRH staff during pre-training in 2014, mid-training in 2015 and post-
training in 2016. The blue bars represent participants who didn’t have resuscitation skills; the red 
bar represents participants using oxygen and suction; the green bars represent participants 
capable of performing bag-valve and mask ventilation 
           The data related to birth asphyxia among RRH inborn NICU admission were collected and 
analyzed by personnel independent of training. Subsequent to the training sessions, there was a 
threefold decrease in inborn NICU admissions from birth asphyxia (Table 3). 
Table 3: In-born NICU admission with birth asphyxia (pre- and post-training) 
  
Pre-Training 
(1s1st 1st Nov to 25th May 
2014) 
Post-Training 
(1s1st1st Jan to 30th June 
2016) 
Inborn NICU Admissions 448 450 
Inborn NICU Admissions with 
Birth Asphyxia (%) 







































 A three-fold reduction in birth asphyxia was observed post-training in comparison to pre-training 
NICU admissions. 
          The integrated approach to systems strengthening at RRH has had mixed results in the 
implementation of the planned activities. The mean implementation rates of all the processes and 
their positive correlation to neonatal and fetal mortality have not been reported due to inadequate 
data. Therefore, we hypothesize that the implementation of intervention activities resulted in 
improvements through improved preparation (triage), communication, and protocol adherence 
(triage, neonatal resuscitation). Neonatal deaths caused by other etiologies were considered stable 
in this analysis.   
Description of Program Costs 
Program costs were collected prospectively to account for multiple sources of funding. A detailed 
project budget was kept throughout the course of the intervention and was reported in United States 
Dollars (US $). The sources of program costs  
a) Kybele-PATH: They paid for overall administration, logistics, and materials for 
educational sessions. In September 2013, Kybele and PATH received a grant from the 
Children’s Investment Fund Foundation and the grant covered the cost travel expenses of 
participants, administrative costs, accommodation, training, incidentals, part of the 
professional time and other direct costs.  
b) Participants: The participants paid for expenses like travel insurance, medicines, visa fees 
and other expenses not reimbursed by the funder.  
c) Professional value time: The participants are practicing medical professionals from North 
America with a background in leading high-quality teams in anesthesiology, neonatology, 
and public health. Some of these participants provided voluntary (uncompensated) services 
which are accounted for as professional value time. The volunteers donated time for their 
work at RRH and the travel time to Accra. Twenty-seven different health professionals 
traveled to Ghana and worked for 484 days at RRH during the entire project; fifteen of 
whom (55%) returned multiple times. The value of volunteered professional time 
represents the opportunity cost of the professionals offering their services within their 
home institutions. Values were determined based on the U.S. Department of Labor, 
National Occupational Employment, and Wage Estimates, Role and Occupation Code37. 
Team members’ time contributions were assigned as follows based on 10-hour work days: 
$ 800 /day for physicians and quality improvement specialist, $ 400/day for midwife/nurse 
practitioner. This method of assigning value is valid in the US but was subjected to 25% 
variation in the sensitivity analysis. 
d) Ghana Health Service (GHS): The GHS initially provided in-country lodging and meals 
for the volunteers, and also invested in the construction cost of new triage pavilion at RRH 
which was subjected to annualization.  
e) Others: All the miscellaneous projects costs uncovered by sources listed from (a) to (d) 
were included as others. Duke Medical Center, East meets West Foundation and volunteers 
donated smaller medical devices, fetal monitors, blood pressure monitors, supplies and 
neonatal hats. These donations were either depreciated at the time of donation or 
consumables and not subjected to annualization.  
The costs incurred by Kybele-PATH along with external aid accounted for 67% of the total 
program cost and the value of professional time accounted for 22% of the total budget. The 
reported total cost of the program was $1,426,325. This analysis does not consider the costs of 
delivering care such as changes in medication usage and inpatient length of stay, but rather focuses 
on the cost of delivering the program. There was no budget for increasing delivery of services, and 
the QI project was structured to primarily improve care in a cost-neutral way such as reducing 
delay and improving communication.  
The reported program costs have been adjusted for inflation and standardized to 2017 USD 
using the Consumer Price Index (CPI). The CPI for all items were used to adjust the costs of 
Kybele-PATH, the physician services component of medical care category was used to adjust the 
costs of professional value time and the medical care commodities component to adjust the costs 
of medical equipment and neonatal hats. The inflation-adjusted total program cost is the US $ 
1,492,434(Table 4).  
Given that most of the funding came from international sources, one of the possible approaches 
was to avoid making purchasing-power parity adjustments to be able to assess the cost-
effectiveness relative to standard thresholds in US $ discussed in the literature. However, in the 
absence of a standard Ghanaian Willingness to Pay threshold (WTP),  the program costs in US $ 
were converted to Ghana’s currency (Ghanaian cedi, GH ¢) to provide a measure of the uncertainty 
in cost-effectiveness estimates38. The standard exchange rates were not used as there are significant 
differences in the relative prices of different goods across countries39,40. On the other 
hand, Purchasing Power Parity (PPP) exchange rates adjust for the different price levels in 
different countries, as PPP is based on a standard basket of goods and services40. It could be argued 
that PPP does not completely adjust for the different relative prices of the goods and services used 
in a particular program across countries, because of the variations in factor endowments across 
countries39. However, PPP conversion factor is preferred as an alternative exchange rate as it 
reflects differences in price levels for both tradable and nontradable goods and services and thus, 
provides a more meaningful comparison of real output39. Accordingly, the inflation-adjusted 
program costs were converted using purchasing power parity conversion factor, GDP (LCU per 
international $) for Ghana, which is the number of units Ghanaian cedi (GH ¢) that would be 
required to buy the same amount of goods and services in the domestic market as a the US $ would 
buy in United States40. The PPP conversion rates for the years 2012 to 2016 were used to adjust 
the program costs and the total PPP-adjusted program costs are GH ¢ 1,640,623 (Table 4). 
 
Table 4: Kybele-PATH -GHS Partnership Total Program Cost in US $ and Ghanaian cedi 
  




PPP- adjusted Costs 
(GH ¢)  
Kybele-PATH 981,577.62 1,019,916.02 1,147,380.89 
Participant  31,938.20 33,699.74 31,611.86 
Value-time 310,100.00 331,938.67 34,6721.88 
GHS 35,378.41 36,757.95 42,602.34 
Others 67,330.43 70,121.76 72,305.82 
Total  1,426,325 1,492,434 1,640,623 
PATH-Program for Appropriate Technology in Health; US $ -United States Dollar; GH ¢ - 
Ghanaian cedi; PPP – Purchasing Power Parity  
 
Perspective is a critical component of CEA as it determines the time horizon for data 
collection, identification of different groups of resources and the measures of cost to be used41. 
The perspective of a CEA needs to be addressed early in the study design and is difficult to be 
addressed at a later stage as is the case with this analysis. Conducting an economic analysis from 
multiple perspectives has been recommended to understand the dynamics of decision making and 
the inclusion of societal perspective as it reflects public interest42. Unfortunately, this retrospective 
CEA is performed from a limited perspective of an NGO implementing a program using volunteer 
services and external aid in LMICs. Due to serious limitations on direct and indirect costs and lack 
of resources needed for data collection a CEA from a societal and Ghana’s Ministry of Health 
perspective hasn’t been conducted. The policy implications resulting from an incomplete 
perspective and the likely impact of omitted costs shall be discussed in the limitations section of 
the paper.  
 
Estimating disability-adjusted life years (DALY) for neonatal and fetal death in Ghana 
 
The disability-adjusted life year (DALY) is the most commonly used summary measure to 
quantify the burden of disease in a given population in low- and middle-income countries43–46.The 
most appropriate measure of the effects of a chronic illness is time, both time lost due to premature 
death and time spent disabled by disease; DALY relies on this assumption45. Therefore, DALYs 
are calculated by adding the adjusted number of years lived with disability (YLDs) and the number 
of years of life lost due to premature mortality(YLL) of future years of life lost through premature 
mortality (YLL)47  
YLD = Number of cases x duration till remission or death x disability weight (1) 
YLL = Number of deaths x life expectancy at the age of death                          (2) 
             DALY = YLD + YLL                                                                                         (3)  
 
The Global Burden of Disease (GBD) project provides important guidance on the 
appropriate methods for computing DALYs. The major philosophical and methodological aspects 
of the DALY calculation has been described and debated in great detail in literature48–50. The most 
recent editions of the GBD have not discounted future DALYs51–53, thereby dispensing the 
assumption that individuals and societies value years of life lost in the current years at a higher 
rate compared to future years of life lost. They also have not applied age weighting, which 
considers the value of years of life lost to vary with age. WHO has historically used both of these 
practices46,54 and this analysis takes this controversy into account and presents the results of both 
the methods. The methods used for discounting DALYs have been well-discussed by other 
authors44. In this study, we used standard values for age weighting and discounting. as seen in 
Table 9.  
Most of the cost-effectiveness analyses of neonatal health interventions in LMICs have 
only included YLLs for neonates9,55,56 but certain studies have shown that interventions in low 
resource settings are likely to result in a small but significant decrease in morbidity57. In this study, 
we calculated YLL and YLD based on the standard DALY component equation. The discount rate 
was set at 3% according to the WHO standard for economic evaluation of health interventions in 
LMICs58. The years of life lost due to premature death were calculated using the average of Ghana-
specific life expectancy at birth for male and female as local life expectancy is recommended as a 
good approximation of life expectancy43. Early neonatal deaths account for 76% of neonatal deaths 
globally and were assumed to be the age at the event for the calculation of YLL59. 
The WHO-CHOICE estimates are not clear on how YLDs were calculated for neonatal 
morbidities13  and the second edition of the Disease Control Priorities Project (DCP2) on neonatal 
indicates that data is scarce60. Age weighting was excluded in the calculation of YLD as several 
arguments suggest that this level of complexity is not appropriate or necessary61, DCP2 practice is 
to exclude it62  and it doesn’t make a major difference to results63. YLD was calculated for three 
key neonatal conditions that can cause disability: preterm birth, infections, and birth asphyxia. 
Disability weights from the ABD study based on Dutch Public Health Status and Forecast study 
values were used in the base case calculation and weights from the GBD study were tested in 
sensitivity analysis64. The Dutch weights were derived using a person trade-off ranking of disease 
stages with interpolation of others, and the high degree of correlation between the Dutch studies 
and GBD studies has been demonstrated65. 
There is discussion regarding inclusion or exclusion of stillbirths in  DALY 
calculations66,67. We do not intend to resolve the ethical debate about assigning a value to lives lost 
in utero but are conscious of the immense cost to families when a fetus dies prior to live birth. In 
the 2013 Global Health Estimates, the WHO recommends inclusion of stillbirths as years of life 
lost and bases the value on standard life tables for life expectancy at birth43. For obvious reasons, 
stillbirths don’t have a YLD component. In our study we considered only fresh stillbirths occurring 
as a result of intrapartum complications as stillbirths. Stillbirths were accordingly included in the 
base analysis and the sensitivity analysis. 
 
Estimating the number of deaths and DALYs averted through the partnership 
This study compares the number of neonatal deaths avoided due to the Kybele-PATH-GHS 
partnership intervention to a “no-intervention” counterfactual that was not actually observed, but 
rather estimated from the quasi-experimental pre- and post-intervention evaluation of the program. 
Typically, NGOs and donor organizations use mortality rates as the standard measure for 
improvement over time. To determine what likely would have occurred if the program had not 
taken place, we considered a steady-state scenario. In this method, the baseline NMR has been 
used to predict the number of neonatal deaths that would have occurred had the intervention not 
been present. The average NMR of 2011 and 2012 has been used as baseline NMR as the 
intervention started in May 2012. Any reduction in the number of maternal deaths is assumed to 
be an improvement, but the attribution of causality is difficult as there are demand-side and supply-
side factors that contribute to NMR within any given region. This approach of estimating neonatal 
deaths averted through a steady state assumption is likely to be an over-estimate of the number of 
neonatal deaths averted by the intervention. For the purposes of this study, this approach shall be 
considered as the best-case scenario. 
A more reasonable approach would have been to observe cases and fatalities and then build 
a hypothesis to attribute the reduction in a number of high-risk cases to the performance of the 
program. In the absence of case fatality rates for the three major causes of neonatal mortality, we 
examined the likely impact of neonatal mortality at the national level on RRH. In this approach, 
we used neonatal mortality rates of Ghana during the intervening years to estimate the number of 
neonatal deaths in RRH. The difference between predicted deaths and observed deaths could be 
considered an improvement due to the intervention. As described above, RRH has a high volume 
of critically ill neonates and this assumption is likely to underestimate the number of deaths 
prevented by the intervention. For the purposes of this study, this approach shall be considered as 
the worst-case scenario. 
The institutional database indicates that the stillbirth rate for the pre-intervention year 
(2011) was 4.31 for 1000 live births, which surprisingly increased to 11.95 in 2012. However, 
while the stillbirth rate decreased over the next years it never reached the pre-intervention rate. 
This could be a case of missing data or detection bias and would be subjected to sensitivity 
analysis. Therefore, to calculate the number of stillbirth deaths averted assuming a steady-state 
stillbirth rate we use the stillbirth rate of 2012 rather than 2011 rate as was used to estimate the 
number of neonatal deaths averted. Following calculation of the deaths prevented, the DALYs 
averted were calculated using the same assumptions discussed above, for determining the DALY 
burden of neonatal deaths and intrapartum stillbirth death.  
 
Assessing the cost-effectiveness of treatment 
The incremental cost-effectiveness ratio (ICER), the difference in costs divided by the 
difference in health effects, is often used to determine the relative cost-effectiveness of 
interventions. For this study, an ICER shows the program cost-effectiveness as measured in 





Estimates of costs, health effects, and ICERs provide clear guidance to policymakers only 
when an explicit threshold standard or threshold has been specified among other conditions68. In 
the absence of an explicit standard or threshold by policymaker, it would be difficult to make an 
objective recommendation. The ceiling ratio(λ) or decision rule is an important component of CEA 
and represents the decision makers’ valuation of a unit of health gain or the relative value against 
which the acceptability of ICERs is judged69.  While explicit cost-effectiveness thresholds are 
available for US and UK, the selection of λ for interventions affecting LMICs has been left to the 
discretion of the analyst68,69. The most common approach has involved the use of thresholds based 
on per capita gross domestic product (GDP). This approach has been promoted by the WHO-
CHOICE project to define cost-effectiveness of an intervention70,71. If the cost of averting one 
DALY is less than three times the national annual GDP per capita then an intervention is deemed 
cost-effective and if it is less than once the country-specific GDP per capita is considered highly 
cost-effective72,73. These thresholds are arbitrary and have numerous limitations, one of them being 
that they are too easily attained68,74. The league table approach derived from the work of World 
Bank recommends $ US 150 per DALY as “attractive’ cost-effectiveness, $ US 25 per DALY as 
‘highly attractive ‘for low-income countries and $ US 500 and $ US 100 per DALY respectively 
for middle-income countries68,69. There are other approaches like preference-elicitation, twice per 
capita gross national income approach which has been discussed elsewhere to define the ceiling 
ratio(λ) for LMICs69. Evidently, each of the approaches has advantages and disadvantages and for 
this study, we present results using multiple approaches to determine the cost-effectiveness of the 
QI intervention.  
 
Cost-effectiveness acceptability curves(CEACs), introduced as an alternative to 
calculating confidence intervals for ICERs with statistical methods, absolve an analyst to commit 
to a fixed value for ceiling ratio38.  CEACs summarize the uncertainty in estimates of cost-
effectiveness and also provide a measure of the decision uncertainty surrounding a specific 
choice38,54,75. They illustrate the probability that data are consistent with a true cost-effectiveness 
ratio falling below a specified ceiling ratio38,75. CEACs are the joint distribution of incremental 
costs and incremental effects and their shape depends solely on the location of incremental cost-
effect pairs with the incremental cost-effectiveness plane38.  We will present CEACs for both the 




Assumptions made in the analysis were subjected to probabilistic sensitivity analysis using 
Monte Carlo simulations run in Crystal Ball (Oracle, Redwood Shores, CA) as an add-in program 
to Microsoft Excel (Microsoft, Redmond, WA). All the assumptions were varied simultaneously 
according to pre-specified distributions. The distributions were assigned according to the inherent 
characteristics of each parameter and according to accepted conventions. The assumptions made 
for calculating DALYs using discounting were varied as uniform distributions around high and 
low estimates as shown in Table 4. The value of professional time was varied at 25%, and the 
number of neonatal deaths and stillbirths were varied around a normal distribution for each 
parameter. Using 10,000 trial simulations a 95% confidence interval for neonatal and fetal deaths 
prevented was obtained independently based on the steady-state NMR and Ghana’s NMR. 
 
Table 5: Sensitivity Analysis Parameters 
Parameter Low Mid High Distribution of 
variation 
Average age  0.01728 0.0192 0.02112 Uniform 
Life expectancy 56.25 62.5 68.75 Uniform 
Stillbirth life expectancy 56.25 62.5 68.75 Uniform 





C (constant) ---- 0.1658 ---- 
r(discount) ---- 0.03 ---- 
B (age weight function) ----- 0.04 ---- 
Disability weight 0.35 0.4 0.55 Uniform 









-1.96* SE Observed 
yearly value 
+ 1.96* SE Normal 
 
2011-2016 Estimated 
number of neonatal deaths 
assuming steady state 
-1.96* SE Observed 
yearly value 
 
+ 1.96* SE Normal 
2012-2016 Observed 
Stillbirths 
-1.96* SE Observed 
yearly value 
 
+ 1.96* SE Normal 
2011-2016 Estimated 
number of neonatal deaths 
using Ghana's NMR 
-1.96* SE Observed 
yearly value 
+ 1.96* SE Normal 






Estimating DALYs averted through the Kybele-PATH-GHS partnership 
 
 
The baseline number of babies delivered at RRH and the outcome data are presented in 
Table 8. Over the entire course of the intervention, NMR decreased by 19% and neonatal deaths 
reduced from 353 to 204 per 1000 live births. If calculated using steady-state NMR assumptions 
464 neonatal deaths were averted with an observed annual rate of mortality reduction ranging from 
-19 to -45% over the four and a half years of intervention. However, if the trend in improvements 
occurring in the country in the form of Ghana’s NMR is used then the neonatal deaths prevented 
would be 182.This number is likely to be an under-estimation of the number of neonatal deaths 
prevented by the intervention as described above (Figure 6). The intrapartum stillbirth rate 
decreased 31%, and an estimated 85 stillbirths were prevented (Figure 7).  
 
Table 6: Baseline data for the Kybele-PATH-GHS Partnership 
Parameter   2011 
 
2012 2013 2014 2015 2016 
Total number of babies 
delivered at RRH 
9599 11338 7549 9672 8807 8129 
Observed number of neonatal 
deaths 
365 353 179 165 208 204 
Observed NMR (per 1000 live 
births) 
36.5 31.12 23.78 17.10 23.59 25.08 
Estimated number of neonatal 
deaths based on steady-state 
NMR assumptions 
332 353 235 301 274 253 
Neonatal deaths prevented due 
to steady-state NMR 
assumptions 
- 39 82 169 97 77 
NMR of Ghana 30.6 29.8 29 28.3 27.5 26.9 
Estimated number of neonatal 
deaths based on Ghana’s NMR 
294 338 219 274 242 219 
Neonatal deaths prevented 
assuming Ghana’s NMR  
 -15 39 108 34 15 
Observed number of 
intrapartum stillbirths 
 135 77 96 83 67 
Observed SBR (per 1,000 live 
births) 
 11.95 10.15 9.91 9.41 8.27 
Estimated number of stillbirths 
based on steady-state SBR 
assumptions 
 135 90 116 105 97 
Stillbirths prevented based on 
steady-state SBR assumptions 
 0 14 20 22 30 
NMR -Neonatal Mortality Rate; SBR- Stillbirth Rate. The data for this table has been collected 
from RRH’s unpublished institutional reports, which has limitations. The table shows the neonatal 
deaths prevented assuming steady-state assumption and Ghana’s NMR (source - World Bank’s 
website: https://data.worldbank.org/indicator/) and stillbirths averted assuming steady-state. The 
baseline rate for the steady-state assumption of neonatal deaths averted is the average NMR of 
2011 and 2012, however, to estimate SBR assuming steady-state only 2012 rate has been used 
because of low quality data. 
Figure 4: Neonatal deaths predicted to have occurred by assumption. The bold blue line 
represents the observed number of neonatal deaths, and the dotted blue line represents the line 
graph to show the changes in observed number of neonatal deaths over time; the bold orange line 
represents the estimated number of deaths using steady-state NMR and the dotted orange line 
represents the line graph to show the changes in estimated number using steady-state NMR over 










































Observed number of neonatal deaths
Estimated number of deaths on steady state NMR assumptions
Estimated number of neonatal deaths using Ghana NMR
Linear (Observed number of neonatal deaths)
Linear (Estimated number of deaths on steady state NMR assumptions)
 
Figure 5: Stillbirths predicted to have occurred by steady-state assumption. The blue line 
represents the observed number of stillbirths and the orange line represents the steady-state 
stillbirth rate estimates. The intermediate graphical distance between both the lines represents the 
number of stillbirths averted by the intervention using the steady-state assumption.  
 
The years of life lost (YLL) per neonatal death were calculated as described above, with 
and without discounting and age weighting as seen in Table 8. Estimating the years of life spent 
disabled requires estimation of an average disability weight, as well as the duration of that 
disability. YLD was calculated for the three major causes of neonatal morbidity – infections, 
asphyxia, and low birth weight. Cost-effectiveness studies conducted in low resource settings have 
assumed the average neonatal period as the age of onset of disability and the duration of disability 





































Observed number of stillbirths Estimated number of stillbirths
component was 0.00018 for every neonatal death prevented. For stillbirths, the calculated YLL 
was 31.55 (62.5 undiscounted) years. 
In total, therefore, the DALY per one neonatal death averted is 31.57 (62.5 undiscounted). 
The steady-state assumption estimates that 462 neonatal deaths were averted by the program 
leading to 14,610 DALYs avoided. If the 84 prevented stillbirths are also included, an additional 
2,641 DALYs were averted. However, if Ghana’s NMR is used then 182 neonatal deaths are 
averted leading to 5,777 DALYs and if the stillbirths are included then a total of 8,418 DALYs are 
averted which is less than 50% of the total DALYs averted using the steady-state assumption. 
 
Table 7: Years of life lost (YLLs) for each neonatal death using different social value choices 








Age weighting modulation factor (K) 1 1 1 1 
Age weighting constant (β)  0.04 0.04 0 0 
Discount rate (r) 0.03 0 0 0.03 
Age at event (a) -  0.0192 0.0192 0.0192 0.0192 
Constant from the age weighting function 
(C) 
0.1658 0.1658 0 0 
Standard life expectancy at birth (L) 62.5 62.5 62.5 62.5 
 Epsilon  2.72 2.72 2.72 2.72 
YLL per each neonatal death averted 31.57 73.98 62.5 28.2 
YLL -years of life lost;  
Cost-Effectiveness Analysis 
Incremental cost-effectiveness ratio (ICER) represents the extra units of outcome achieved per 
extra dollar/ Ghanaian cedi spent. For the best- case scenario (using steady-state assumption), 
compared to status quo, the QI intervention costs $ 1,492,434 more but also results in 1,7312 
DALYs averted for an incremental cost-effectiveness ratio of $ 86/DALY averted. In the context 
of most commonly used approach of thresholds based on per capita gross GDP ($ 1649, Ghana’s 
average GDP for 2012-2016), it is likely that the QI intervention for reducing neonatal deaths is 
highly cost-effective. For the worst-case scenario, compared to a status quo, the QI intervention 
costs $ 1,492,434 more but also results in 8,412 DALYs averted for an incremental cost-
effectiveness ratio of $177 /DALY averted. In the context of commonly accepted willingness to 
pay thresholds of $ 1649 (based on Ghana’s average GDP for 2012-2016), it is likely that the QI 
intervention for reducing neonatal deaths is highly cost-effective. 
In the league table approach, the World Bank recommended a threshold of $ 100 for ‘highly 
attractive’ and $ 500 for ‘attractive’ cost-effectiveness for a middle-income country like Ghana69. 
For the best-case scenario, compared to a status-quo, the QI intervention costs $ 1492,434 more 
but also results in 17,312 DALYs for an incremental cost-effectiveness ratio of $ 86 /DALY 
averted. In the context of World Bank recommended threshold of $100, it is likely that the QI 
intervention for reducing neonatal deaths is ‘highly attractive’ for cost-effectiveness. For the 
worst-case scenario, compared to a status-quo, the QI intervention costs $ 1492,434 more but also 
results in 8,412 DALYs for an incremental cost-effectiveness ratio of $177 /DALY averted. In the 
context of World Bank recommended of thresholds in the league table approach, it is likely that 
the QI intervention for reducing neonatal deaths is ‘attractive’ for cost-effectiveness. Thus, CEA 
of interventions in LMICs depend on the approach used and the corresponding cost-effectiveness 
threshold and therefore are less likely to provide clear guidance to local policymakers.  
We constructed CEACs to provide a measure of the decision uncertainty by plotting the 
proportion of incremental cost-effect pairs that are cost-effective for a range of λ values starting 
with 0 to GH ¢ 250 for the QI intervention using steady states (Figure 6) and up to GH ¢ 500 for 
QI intervention using NMR rates. (Figure 7). CEACs provide the probability of the cost-
effectiveness of QI intervention for a range of λ that a decision maker might consider as the 
maximum cost that they are willing to pay (WTP) for a DALY averted in one year. As shown in 
Figure 6, for the base case scenario, if the decision maker were willing to pay GH ¢ 200 per DALY, 
the probability of QI intervention being cost-effective was 0.98. The probability of QI intervention 
being cost-effective was 1 when the WTP was GH ¢250. As shown in Figure 7, for the worst-case 
scenario, if the decision maker were willing to pay GH ¢200 per DALY, the probability of QI 
intervention being cost-effective was 0.67. The probability of QI intervention being cost-effective 
was 0.90 when the WTP was GH ¢ 500. 
 
 





















































Willingness to Pay (GH ¢/DALY)
Figure 7 – Cost-effectiveness acceptability curve for QI intervention using Ghana’s NMR  
 
Sensitivity Analysis: Considering the Changing Environment 
This study report results from a completed intervention, but several assumptions were 
needed to be made regarding the unobserved counterfactual. Table 4 shows the variables that were 
added and describes how uncertainty was handled for each. We varied performance as a normal 
distribution centered around an observed mean to account for uncertainty. We then repeated the 
distribution sampling using Monte Carlo simulations independently for both steady-steady state 
assumptions (best-case scenario) and Ghana’s NMR (worst-case scenario). The results for both the 
scenarios are presented in Table 8 & 9. The tornado charts for steady-state assumption and Ghana’s 
NMR (Figure 8 & 9) display the 5th and 95th percentile estimates for each assumption and how that 
variation affects the estimates of the ICER. The five assumptions accounting for maximum 
variation in ICER estimation are identical in both tornado charts.  The most significant assumption 
in both tornado charts is the number of stillbirths in 2012, which are thrice the number of stillbirths 
observed in 2011. This assumption accounts for 30% variation in the ICER estimate for both 
scenarios. The next most significant assumption was the estimated number of neonatal deaths in 
2012 using steady state and Ghana’s NMR, which accounted for 9% of the variation. The 2012 
neonatal deaths were estimated using the average NMR of 2011 and 2012. Finally, the number of 
neonatal deaths observed in 2012 which accounted for 8% of the variation. Variables contributing 
to >4% of the variation in ICER estimates have been shown in the tornado chart and the top 
variables contributing to maximum variation are all assumptions made from the low quality, 
unpublished institutional data.  
 
Table 8: Sensitivity Analysis: Using steady-state rate 
DALYs-Disability Adjusted Life Years; CER – Cost-effectiveness ratio; CI- Confidence Interval 
 
Table 9: Sensitivity Analysis: Using Ghana’s NMR  
 
Parameter       DALYs     95% CI     CER 95% CI 
Discounting neonatal 
deaths 
5777 2663-8891 284 202-362 
Discounting neonatal 
deaths and stillbirths 
8418 4372-12464 195 166- 224 
Undiscounted neonatal 
deaths 
11438 5222-17654 143 113-173 
Undiscounted neonatal 
deaths and stillbirths 
16669 8598-24740 98 69-127 
 
 DALYs-Disability Adjusted Life Years; CER – Cost-effectiveness ratio; CI- Confidence Interval 
Parameter DALYs 95% CI CER 95% CI 
Discounting neonatal deaths 14610 11490-17730 112.29 81-143 
Discounting neonatal deaths 
and stillbirths 
17251 13302-21200 95.1 66-124 
Undiscounted neonatal 
deaths 
28925 22534-35316 56.72 41-73 
Undiscounted neonatal 
deaths and stillbirths 
34156 26142-42170 48.03 33-63 
 
Figure 8. Tornado chart of ICER for discounted calculations of neonatal deaths estimated from 
steady-state assumption and stillbirths showing variables contributing >4 % of the variation in 
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Figure 9. Tornado chart of ICER for discounted calculations of neonatal deaths estimated from 
Ghana’s NMR and stillbirths showing all variables contributing >= 2% of the variation in the 
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This study presents the cost-effectiveness of an integrated QI intervention using prospectively 
collected financial records and outcome data. The objective is to enhance accountability to the 
funding organization for the actions of NGOs like Kybele and PATH and also direct other NGOs 
planning similar interventions. Our analysis shows that with GH ¢ 1,640,623 invested, including 
GH ¢ 0.3 million worth of donated professional time, the Kybele-PATH- GHS partnership was 
able to prevent between 182 (worst-case scenario) and 464 (best-case scenario) neonatal deaths 
and 85 intrapartum stillbirths. This amounts to averting 8,418 discounted DALYs for the worst-
case scenario) and 17,251 discounted DALYs for the best-case scenario. The sensitivity analysis 
provides confidence that the DALYs averted ranged from 4,372 to 12,464 for the worst-case 
scenario and 13,302 to 21,200 for the best-case scenario when the assumptions were altered. The 
probability that the QI intervention is cost-effective is above 0.98 over a threshold value of GH ¢ 
200 for the best-case scenario, However, the probability that the QI intervention is cost-effective 
is above 0.90 over a threshold of GH ¢ 500 for the worst-case scenario. 
Attribution of causality is difficult in studies such as this as it would be difficult to 
systematically control the intervention. It is likely that the “no intervention” counterfactual would 
have involved increasing mortality rates as a consequence of increasing prevalence of high-risk 
cases. In the absence of case fatality rates, it is difficult to argue whether RRH has been able to 
reduce NMR lower than another regional referral hospital. 
NGOs using QI intervention to reduce neonatal and fetal mortality do not routinely report 
cost-effectiveness. The CHEERS guidelines for reporting cost-effectiveness were followed to the 
extent possible in this retrospective analysis58. The QI intervention was intended to promote higher 
quality and more efficient care, which could, in turn, result in lower costs. For instance, providing 
rapid interventions for neonatal jaundice could help mitigate expensive treatments such as 
intensive care admission and phototherapy. However,this study does not assess how the costs of 
clinical care changed at RRH during the course of the intervention. This is a single study-based 
estimate that serves as a sufficient source to represent the cost of long-term coaching, leadership 
development, and quality improvement that other NGOs may attempt in similar facilities.  
One important theme that this analysis ignores is that Ridge Hospital serves as a referral 
hospital, and since the Kybele –PATH- GHS partnership began, outreach to referral centers, 
educational modules and strengthening of protocols has occurred. These benefits although not 
elucidated, will likely serve to underestimate the cost-benefit analysis conducted here if a regional 
(as distinct to the single hospital) approach were to be taken. Further analysis at the regional levels 
is urgently needed to deepen our understanding. 
 
Strengths and Limitations 
This study has several strengths. A real-world intervention has been retrospectively 
analyzed instead of relying on prospectively developed hypothetical constructs. This program has 
been built on the previously established relationship between Kybele and the GHS through the 
maternal program and establishing an “Obstetric Center of Excellence” at RRH23. Kybele-PATH 
were successful in securing a grant to implement an integrated approach to improve neonatal 
outcomes. By consistently involving GHS, the Kybele-PATH partners were able to create a sense 
of local collaboration. NGOs working on improving neonatal and fetal health normally don’t report 
cost-effectiveness and this study could encourage more NGOs to report their cost-effectiveness 
findings and promote transparency of their actions to donors and the host country.  The project 
provided the development of leadership and QI skills to sustain healthcare improvements at Ridge 
and other regional centers within the GHS. By investing in the renovation of NICU, GHS 
demonstrated the value the government places on the program, which is likely to influence the 
sustainability of the project.  
There are also weaknesses present in the study that are important to address. This study 
doesn’t provide a societal or Ghana’s Ministry of Health perspective and has limited policy 
implications at the local level. The project was conducted using grant funding from an international 
organization and volunteer time donated by foreign experts. This calls for challenging estimation 
of the value of professional time. It is extremely unlikely for tertiary hospitals in low and middle-
income counties to have access to highly skilled professionals to mentor similar interventions. This 
study also suffers from low quality and incomplete health care data seen in most studies from 
LMICs77 - the institutional case fatality rates weren’t available, data was missing during the 
transition from the manual database to electronic database, incomplete implementation data on 
different modules. It is likely that a strong critic could argue that the calculations and findings of 
the study have been built on the poor quality of data. The probabilistic sensitivity analysis and the 
tornado charts do support some of the criticism. QI interventions are generally time intensive and 
are not replicable in different settings owing to shortage of manpower and funding. This study was 
conducted in a single hospital and it is likely that the exact number of neonatal deaths averted can’t 
be known considering that there has been a significant increase in the number of babies delivered. 
The large increases in patient volume were not anticipated at the project outset and could have 
resulted from changes in referral patterns in Accra, insurance incentives promoting institutional 
delivery, and community recognition of improving care at RRH. The NICU at RRH doesn’t meet 
international standards and RRH is a moderately well-staffed and equipped hospital. This would 
limit the external validity as the cost-effectiveness of QI interventions depends on the hospital and 
clinic settings.  
Future efforts need to be directed towards strengthening the newborn intensive care unit, 
which treats the most vulnerable newborn.  It is our hope that the selection of clinical champions, 
training in QI and leadership, and clinical care strengthening across various clinical areas resulted 
in numerous process improvements which have been sustained. While the maternal program 
demonstrated that NGOs with voluntary participation can be successful, this program hypothesizes 
that NGOs supported by external funding are likely to forge stronger relationships with local 
government, collaborate with multiple partners and promote long-sustainability of improvement 
processes. The long-term sustainability of this integrated approach at RRH and the scalability of 
this approach to other regional hospitals requires careful consideration. Assessing the longer-term 
effects of the intervention will be the subject of future publications 
 
Interpretation 
As national governments in low and middle countries prioritize their strategies to reduce 
neonatal mortality to achieve SDG targets, an integrated approach to systems strengthening holds 
promise. There is 0.90 probability of such interventions being cost-effective at a willingness to 
pay threshold of GH ¢ 500.We report that it may be highly cost-effective to support QI 
methodologies developed jointly by local teams and visiting professionals to reduce neonatal 
mortality in complex environments like referral hospitals. Such programmatic efforts are likely to 
sustain the change by developing adequate internal capacity and we believe NGOs can play an 





The Kybele-PATH- Ghana Health Service partnership successfully reduced neonatal and 
fetal mortality over four and a half years using an integrated quality improvement program. It is 
estimated that 182 (±99) neonatal deaths and 85 (±77) stillbirths were prevented amounting to 
8418 DALYs (± 4046) averted. The probability that the QI intervention is cost-effective is 0.90 at 
a willingness to pay threshold (WTP) of GH ¢ 500. This study supports the hypothesis that using 
an integrated approach to systems strengthening in referral hospitals holds promise for producing 
cost-effective outcomes for mothers with high-risk pregnancies in Ghana and in other low resource 
settings. Additional similar experiences need to be studied in other settings, but it seems likely that 
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